{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:24:10Z","timestamp":1786947850808,"version":"build-2736575974"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Patients with systemic lupus erythematosus (SLE) exhibit heterogeneous renal courses after acute kidney injury (AKI). This study applied latent class mixed modeling to identify AKI trajectory phenotypes in SLE, developed a risk-stratification model using early post-AKI data, and explored whether hydroxychloroquine (HCQ) use is associated with AKI trajectory class membership.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter retrospective study used MIMIC-IV for model development and internal assessment and eICU, NWICU, and local cohorts for exploratory external assessment. Adult SLE patients with AKI were included. The primary model was a race-free, no-imbalance-correction LASSO logistic regression model. Performance was assessed with AUC, Brier score, calibration intercept, and calibration slope. Bootstrap optimism correction was applied. A non-overlap sensitivity analysis examined the influence of structural predictor-outcome overlap. HCQ was evaluated using multivariable logistic regression and propensity score matching.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 279 MIMIC patients, three AKI trajectories were identified (progressive 9.3%, recovery 19.4%, stable\u00a071.3%). The primary race-free LASSO model achieved an apparent AUC of 0.761 (optimism-corrected: 0.706) and a Brier score of 0.086 (corrected: 0.092). When assessed against a non-overlapping post-48-hour renal endpoint, discrimination diminished substantially (AUC 0.593). Exploratory external assessments were event-limited: the main SLE external discrimination subsets contained 6 events in eICU, 3 events in NWICU, and 1 event in the local cohort; therefore, these estimates were considered descriptive rather than definitive validation. HCQ showed an exploratory association not interpretable as causal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides an exploratory risk-stratification framework for early AKI trajectory patterns in SLE. The apparent discrimination was substantially attenuated after removing predictor-outcome overlap and adjusting for optimism. External assessments were event-limited and should be interpreted as exploratory transportability assessments rather than definitive evidence of generalizability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1910588","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:25:21Z","timestamp":1786944321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Early creatinine dynamics for stratifying acute kidney injury trajectories in patients with systemic lupus erythematosus: an exploratory multicenter retrospective study"],"prefix":"10.3389","volume":"17","author":[{"given":"Rui","family":"Yue","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University","place":["Huaian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiting","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Huaian Clinical College of Xuzhou Medical University","place":["Huaian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Huaian Clinical College of Xuzhou Medical University","place":["Huaian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University","place":["Huaian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqian","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University","place":["Huaian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University","place":["Huaian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University","place":["Huaian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University","place":["Huaian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University","place":["Huaian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"11","author":"Parodis","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/09612033241227027","article-title":"Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis","volume":"33","author":"Akhlaq","year":"2024","journal-title":"Lupus"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06629-1","article-title":"Predictors of treatment outcomes in lupus nephritis with severe acute kidney injury and requirement of dialytic support","volume":"42","author":"M\u00e1rquez-Macedo","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup","volume":"13","author":"Chawla","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.kint.2020.04.020","article-title":"Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference","volume":"98","author":"Ostermann","year":"2020","journal-title":"Kidney Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s40520-024-02701-1","article-title":"The relationship between trajectories of renal oxygen saturation and acute kidney injury: a prospective cohort study with a secondary analysis","volume":"36","author":"Liu","year":"2024","journal-title":"Aging Clin Exp Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1027","article-title":"Discovering subpopulation structure with latent class mixed models","volume":"21","author":"McCulloch","year":"2002","journal-title":"Stat Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra2302038","article-title":"Artificial intelligence and machine learning in clinical medicine, 2023","volume":"388","author":"Haug","year":"2023","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-001140","article-title":"Systemic lupus in the era of machine learning medicine","volume":"11","author":"Zhan","year":"2024","journal-title":"Lupus Sci Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1390-1","article-title":"A clinically applicable approach to continuous prediction of future acute kidney injury","volume":"572","author":"Toma\u0161ev","year":"2019","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2196\/62932","article-title":"Explainable machine learning model for predicting persistent sepsis-associated acute kidney injury: development and validation study","volume":"27","author":"Jiang","year":"2025","journal-title":"J Med Internet Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.2017.71s1-po4123","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel","year":"2024","journal-title":"Jama"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.32190","article-title":"Hydroxychloroquine and cardiovascular events in patients with systemic lupus erythematosus","volume":"7","author":"Grimaldi","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221129774","article-title":"Hydroxychloroquine use reduces mortality risk in systemic lupus erythematosus: a systematic review and meta-analysis of cohort studies","volume":"31","author":"Cai","year":"2022","journal-title":"Lupus"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30393","article-title":"Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus","volume":"10","author":"Peng-Cheng","year":"2024","journal-title":"Heliyon"},{"key":"B17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"2024 clinical practice guideline for the management of LUPUS NEPHRITIS","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12916-023-02858-y","article-title":"Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges","volume":"21","author":"Rahnenf\u00fchrer","year":"2023","journal-title":"BMC Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106043","article-title":"Explainable, trustworthy, and ethical machine learning for healthcare: a survey","volume":"149","author":"Rasheed","year":"2022","journal-title":"Comput Biol Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s42256-019-0048-x","article-title":"Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead","volume":"1","author":"Rudin","year":"2019","journal-title":"Nat Mach Intell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/mcc.0000000000001213","article-title":"Hemodynamic management of acute kidney injury","volume":"30","author":"De Backer","year":"2024","journal-title":"Curr Opin Crit Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15429","article-title":"Risk factors for vancomycin-associated acute kidney injury: a systematic review and meta-analysis","volume":"88","author":"Kim","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042052","article-title":"Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application","volume":"23","author":"Kan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25616","article-title":"Hydroxychloroquine associated with lower glomerular filtration rate decline in lupus nephritis","volume":"78","author":"Garg","year":"2026","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/1759720x211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/09612033241230377","article-title":"Network pharmacology and molecular docking to elucidate the common mechanism of hydroxychloroquine treatment in lupus nephritis and IgA nephropathy","volume":"33","author":"Chen","year":"2024","journal-title":"Lupus"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4331\/wjbc.v16.i2.107042","article-title":"Chloroquine and hydroxychloroquine: immunomodulatory effects in autoimmune diseases","volume":"16","author":"Al-Hamadani","year":"2025","journal-title":"World J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.47665\/tb.39.4.010","article-title":"Effects of artemisinin and hydroxychloroquine on cytokines in experimental sepsis","volume":"39","author":"B\u00fcy\u00fckcavlak","year":"2022","journal-title":"Trop BioMed"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"Bmj"},{"key":"B31","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/m18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1910588\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:25:22Z","timestamp":1786944322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1910588\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2026.1910588"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1910588","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"1910588"}}